In the News - Doherty Clinical Trials' CMO and CEO featured in The Age, with Professor Sharon Lewin.

Speaking about the importance of human challenge trials, the article coincides with the launch of Doherty Clinical Trials' facility in East Melbourne.

Doherty Clinical Trials' Chief Medical Officer, Professor James McCarthy and CEO, Dr Andrew Brockway (pictured above) were this week featured in The Age explaining the importance of human challenge trials, how they're administered and the valuable insights they can deliver to further advance medical research and help Victoria, and potentially the world, prepare for the next pandemic.

Coinciding with the launch and unveiling of the facility, currently based in East Melbourne, the article also speaks with Doherty Institute director and Doherty Clinical Trials board member, Professor Sharon Lewin, who articulated the focus of the unit - the first purpose-built human challenge facility in the Southern Hemisphere.

You can read the full article here.

Image taken from The Age article 'Virus volunteers to help Melbourne’s new human trials clinic prepare for the next pandemic', captured by Paul Jeffers.

November 6, 2024
Event
Dr Andrew Brockway at AusBiotech 2024

Dr Andrew Brockway's panel, 'Clinical Trials in Australia: Performance, Competitive Advantages, Challenges and Evolving Policy' at AusBiotech 2024

November 27, 2024
News
Doherty Clinical Trials at the 10th National Institutional Biosafety Committee Forum

Senior Lab Manager, Vanessa Mollard represented Doherty Clinical Trials at the forum in Canberra

June 5, 2024
In the Media
Doherty Clinical Trials on The House of Wellness

Highlighting the vital work of Doherty Clinical Trials and sharing why participants find it so rewarding.

November 16, 2023
News
Doherty Clinical Trials launches the #mRNA Platform Incubator Network

Doherty Clinical Trials launches the #mRNA Platform Incubator Network in collaboration with Moderna and other leading minds in bio-medical research

April 2, 2024
In the Media
In the News - CEO Dr Andrew Brockway interviewed by The Guardian

Delving further into the Doherty Clinical Trials experience and the purposes of human challenge trials, the article is another feature highlighting the company’s launch.